How do I install the Ppgl Pediatric Surgical Approach skill?

Run npx skillmds@latest add dromlakhani/ppgl-pediatric-surgical-approach in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Ppgl Pediatric Surgical Approach safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Ppgl Pediatric Surgical Approach?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Ppgl Pediatric Surgical Approach free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Ppgl Pediatric Surgical Approach?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Ppgl Pediatric Surgical Approach by dromlakhani

Name: Ppgl Pediatric Surgical Approach
Rating: 4.2 (5 reviews)
Author: dromlakhani

Ppgl Pediatric Surgical Approach

Determines surgical approach for PPGL in children considering tumor size, suspected pathogenic gene variants, and hereditary tumor syndromes. Chooses between laparotomy and endoscopic surgery based on child's size and genetic risk; incorporates family history and genetic testing results in decision-making, with triggers such as 'Child diagnosed with PPGL requiring surgery,' 'Need to select surgical approach for pediatric PPGL,' and 'Evaluating surgical options in child with genetic syndrome.'

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Pediatric PPGL Surgical Approach Considerations

STEP 1 — Gather Information

Collect child's age, weight, and body surface area; tumor diameter via contrast-enhanced CT or MRI; family history of PPGL or hereditary tumor syndromes (VHL, RET, SDHx, NF1, MEN2); results of germline genetic testing if available; biochemical confirmation with fractionated metanephrines or plasma-free metanephrines; presence of syndromic features.

STEP 2 — Rule In / Rule Out

If tumor diameter ≤ 3 cm AND no high‑risk pathogenic variant (VHL, RET, SDHB) AND no known hereditary tumor syndrome → proceed to endoscopic evaluation; otherwise → proceed to laparotomy evaluation.

STEP 3 — Classify or Stratify

Endoscopic pathway: classify as laparoscopic adrenalectomy (LA) for children ≥5 years or tumor accessible via standard ports; consider robot‑assisted laparoscopic adrenalectomy (RAA) if available and child size permits.
Laparotomy pathway: classify as open transabdominal adrenalectomy (OA) for tumors >3 cm or suspected multifocal/bilateral disease; consider posterior retroperitoneoscopic approach only if expertise exists and tumor is small and lateral.

STEP 4 — Decide

Endoscopic: schedule LA or RAA after preoperative α‑blockade; Laparotomy: schedule OA with prepared blood products and experienced team; arrange genetic counseling and postoperative surveillance per hereditary syndrome.

Clinical Guardrails / Mimics / Pitfalls

Avoid laparoscopy in tumors >3 cm due to bleeding risk; ensure α‑blockade ≥7‑14 days preoperatively; do not rely on endoscopic approach in VHL, RET, or SDHB carriers without multidisciplinary review; false‑negative genetic testing does not exclude hereditary syndrome; monitor for intraoperative hemodynamic instability even in small tumors.

Concrete Clinical Example

A 6‑year‑old girl with episodic hypertension, abdominal tumor 2.4 cm on MRI, family history of VHL, germline VHL pathogenic variant confirmed. Despite tumor ≤3 cm, hereditary syndrome triggers laparotomy; she undergoes open transabdominal adrenalectomy with uneventful recovery.

Source: Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025, I-10-3, doi:10.1507/endocrj.EJ25-0165

---name: ppgl-pediatric-surgical-approachdescription: Determines surgical approach for PPGL in children considering tumor size, suspected pathogenic gene variants, and hereditary tumor syndromes. Chooses between laparotomy and endoscopic surgery based on child's size and genetic risk; incorporates family history and genetic testing results in decision-making, with triggers such as 'Child diagnosed with PPGL requiring surgery,' 'Need to select surgical approach for pediatric PPGL,' and 'Evaluating surgical options in child with genetic syndrome.'---# Pediatric PPGL Surgical Approach Considerations## STEP 1 — Gather InformationCollect child's age, weight, and body surface area; tumor diameter via contrast-enhanced CT or MRI; family history of PPGL or hereditary tumor syndromes (VHL, RET, SDHx, NF1, MEN2); results of germline genetic testing if available; biochemical confirmation with fractionated metanephrines or plasma-free metanephrines; presence of syndromic features.## STEP 2 — Rule In / Rule OutIf tumor diameter ≤ 3 cm AND no high‑risk pathogenic variant (VHL, RET, SDHB) AND no known hereditary tumor syndrome → proceed to endoscopic evaluation; otherwise → proceed to laparotomy evaluation.## STEP 3 — Classify or StratifyEndoscopic pathway: classify as laparoscopic adrenalectomy (LA) for children ≥5 years or tumor accessible via standard ports; consider robot‑assisted laparoscopic adrenalectomy (RAA) if available and child size permits. Laparotomy pathway: classify as open transabdominal adrenalectomy (OA) for tumors >3 cm or suspected multifocal/bilateral disease; consider posterior retroperitoneoscopic approach only if expertise exists and tumor is small and lateral.## STEP 4 — DecideEndoscopic: schedule LA or RAA after preoperative α‑blockade; Laparotomy: schedule OA with prepared blood products and experienced team; arrange genetic counseling and postoperative surveillance per hereditary syndrome.## Clinical Guardrails / Mimics / PitfallsAvoid laparoscopy in tumors >3 cm due to bleeding risk; ensure α‑blockade ≥7‑14 days preoperatively; do not rely on endoscopic approach in VHL, RET, or SDHB carriers without multidisciplinary review; false‑negative genetic testing does not exclude hereditary syndrome; monitor for intraoperative hemodynamic instability even in small tumors.## Concrete Clinical ExampleA 6‑year‑old girl with episodic hypertension, abdominal tumor 2.4 cm on MRI, family history of VHL, germline VHL pathogenic variant confirmed. Despite tumor ≤3 cm, hereditary syndrome triggers laparotomy; she undergoes open transabdominal adrenalectomy with uneventful recovery.**Source:** Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025, I-10-3, doi:10.1507/endocrj.EJ25-0165

Frequently asked questions